Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

The rapid development of vaccines against SARS-CoV-2 has been a critical milestone in responding to the COVID-19 pandemic, yet the continued evolution of ...

SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate ...

The Lambda variant is one of 11 official SARS-CoV-2 variants recognised by the World Health Organization. It was first ...

Millions of COVID-19-associated illnesses and outpatient visits as well as thousands of hospitalizations and deaths continued to occur annually in the United States from late 2022 through 2024, ...

Key takeawaysA UCLA-led research team demonstrated that when human immune enzymes break up the spike protein of the virus ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

The CDC has 1 million participants in its travel bio surveillance program, 'marking a significant milestone in the United ...

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...